![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 10, 8779-8786, March 5, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the
Department of Microbiology and Cancer Center and the
Department of Physiology, University of Virginia, Charlottesville, Virginia 22908, the ||Department of Neuroscience, University of Pennsylvania, Philadelphia, Pennsylvania 19104, and the ¶Center for Biodefense, George Mason University, Manassas, Virginia 20110
Src family kinases (SFKs) are abundant in chromaffin cells that reside in the adrenal medulla and respond to cholinergic stimulation by secreting catecholamines. Our previous work indicated that SFKs regulate acetylcholine- or nicotine-induced secretion, but the site of modulatory action was unclear. Using whole cell recordings, we found that inhibition of SFK tyrosine kinase activity by PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo(3,4-d)pyrimidine) treatment or expression of a kinase-defective c-Src reduced the peak amplitude of nicotine-induced currents in chromaffin cells or in human embryonic kidney cells ectopically expressing functional neuronal
3
4
5 acetylcholine receptors (AChRs). Conversely, the phosphotyrosine phosphatase inhibitor, sodium vanadate, or expression of mutationally activated c-Src resulted in enhanced current amplitudes. These results suggest that SFKs and putative phosphotyrosine phosphatases regulate the activity of AChRs by opposing actions. This proposed model was supported further by the findings that SFKs physically associate with the receptor and that the AChR is tyrosine-phosphorylated.
Received for publication, September 2, 2003 , and in revised form, November 24, 2003.
* This work was supported by Grant P01 CA40042 from the NCI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Dept. of Surgery, University of British Columbia, Vancouver, B. C. V6H 3Z6, Canada.
** To whom correspondence should be addressed: Dept. of Microbiology, University of Virginia Health System, P. O. Box 800734, Charlottesville, VA 22908. Tel.: 804-924-2352; Fax: 804-982-0689; E-mail: sap{at}virginia.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Arredondo, A. I. Chernyavsky, D. L. Jolkovsky, K. E. Pinkerton, and S. A. Grando Receptor-mediated tobacco toxicity: acceleration of sequential expression of {alpha}5 and {alpha}7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke FASEB J, May 1, 2008; 22(5): 1356 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Chernyavsky, J. Arredondo, T. Piser, E. Karlsson, and S. A. Grando Differential Coupling of M1 Muscarinic and {alpha}7 Nicotinic Receptors to Inhibition of Pemphigus Acantholysis J. Biol. Chem., February 8, 2008; 283(6): 3401 - 3408. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Webb, H. Zhang, D. Majumdar, and A. F. Horwitz {alpha}5 Integrin Signaling Regulates the Formation of Spines and Synapses in Hippocampal Neurons J. Biol. Chem., March 9, 2007; 282(10): 6929 - 6935. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Viviani, F. Gardoni, S. Bartesaghi, E. Corsini, A. Facchi, C. L. Galli, M. Di Luca, and M. Marinovich Interleukin-1beta Released by gp120 Drives Neural Death through Tyrosine Phosphorylation and Trafficking of NMDA Receptors J. Biol. Chem., October 6, 2006; 281(40): 30212 - 30222. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Charpantier, A. Wiesner, K.-H. Huh, R. Ogier, J.-C. Hoda, G. Allaman, M. Raggenbass, D. Feuerbach, D. Bertrand, and C. Fuhrer {alpha}7 Neuronal Nicotinic Acetylcholine Receptors Are Negatively Regulated by Tyrosine Phosphorylation and Src-Family Kinases J. Neurosci., October 26, 2005; 25(43): 9836 - 9849. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Gritz, C. Dresler, and L. Sarna Smoking, The Missing Drug Interaction in Clinical Trials: Ignoring the Obvious Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2287 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kumar and S. Meizel Nicotinic Acetylcholine Receptor Subunits and Associated Proteins in Human Sperm J. Biol. Chem., July 8, 2005; 280(27): 25928 - 25935. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Martin, G. Alonso, and N. C. Guerineau Agrin mediates a rapid switch from electrical coupling to chemical neurotransmission during synaptogenesis J. Cell Biol., May 9, 2005; 169(3): 503 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fischer, D.-M. Liu, A. Lee, J. C. Harries, and D. J. Adams Selective Modulation of Neuronal Nicotinic Acetylcholine Receptor Channel Subunits by Go-Protein Subunits J. Neurosci., April 6, 2005; 25(14): 3571 - 3577. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Cho, W. Song, K. Leitzell, E. Teo, A. D. Meleth, M. W. Quick, and R. A. J. Lester Rapid Upregulation of {alpha}7 Nicotinic Acetylcholine Receptors by Tyrosine Dephosphorylation J. Neurosci., April 6, 2005; 25(14): 3712 - 3723. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |